Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $15.80 million. The enterprise value is -$36.64 million.

Market Cap	15.80M
Enterprise Value	-36.64M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

SNSE has 25.08 million shares outstanding. The number of shares has decreased by -18.85% in one year.

Shares Outstanding	25.08M
Shares Change (YoY)	-18.85%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	34.49%
Owned by Institutions (%)	9.25%
Float	16.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.27
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.07, with a Debt / Equity ratio of 0.10.

Current Ratio	12.07
Quick Ratio	n/a
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-244.51

Financial Efficiency

Return on equity (ROE) is -46.70% and return on invested capital (ROIC) is -54.26%.

Return on Equity (ROE)	-46.70%
Return on Assets (ROA)	-40.90%
Return on Capital (ROIC)	-54.26%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.77% in the last 52 weeks. The beta is 0.05, so SNSE's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-48.77%
50-Day Moving Average	1.03
200-Day Moving Average	0.86
Relative Strength Index (RSI)	38.91
Average Volume (20 Days)	84,877

Short Selling Information

The latest short interest is 289,885, so 1.16% of the outstanding shares have been sold short.

Short Interest	289,885
Short Previous Month	282,573
Short % of Shares Out	1.16%
Short % of Float	1.76%
Short Ratio (days to cover)	1.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.79M
Pretax Income	-31.92M
Net Income	-31.92M
EBITDA	-29.05M
EBIT	-31.79M
Earnings Per Share (EPS)	-$1.21

Full Income Statement

Balance Sheet

The company has $58.08 million in cash and $5.64 million in debt, giving a net cash position of $52.44 million or $2.09 per share.

Cash & Cash Equivalents	58.08M
Total Debt	5.64M
Net Cash	52.44M
Net Cash Per Share	$2.09
Equity (Book Value)	58.47M
Book Value Per Share	2.33
Working Capital	55.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$27.90 million and capital expenditures $91,000, giving a free cash flow of -$27.81 million.

Operating Cash Flow	-27.90M
Capital Expenditures	91,000
Free Cash Flow	-27.81M
FCF Per Share	-$1.11

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	18.85%
Shareholder Yield	18.85%
Earnings Yield	-201.95%
FCF Yield	-175.99%

Analyst Forecast

The average price target for SNSE is $4.33, which is 587.19% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.33
Price Target Difference	587.19%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3